Related Articles
Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer
BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells
Potent anti-metastatic activity of combretastatin-A4
Inhibitory effects of docosyl p-coumarate on DNA topoisomerase activity and human cancer cell growth
Chemoenzymatic preparation of intermediates for the taxol side chain and analogs